Medicus Pharma partners with Swanielle to expand BCC drug trial to Asia-Pacific
Canadian life sciences company Medicus Pharma has partnered with Japanese healthcare consultancy Swanielle to expand its Phase II clinical trial …
Post
-
-
Sudo Biosciences begins trial of drug candidate for neuroinflammatory conditions
US-based biopharmaceutical company Sudo Biosciences has initiated a Phase I trial of SUDO-550, a drug candidate designed to treat neuroinflammatory …
-
Four oral GLP-1R products in Phase III trials as race intensifies
The popularity of GLP-1 receptor (GLP-1R) subcutaneous treatments for obesity has proved the demand for the drugs, but the lack …
-
Novocure seeks approval after pancreatic cancer wearable scores at Phase III
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic …
-
Sidra Medicine conducts paediatric congenital hyperinsulinism trial
Qatar Foundation member Sidra Medicine has conducted the industry-sponsored ‘sunRIZE’ trial for paediatric congenital hyperinsulinism. The first pharmaceutical trial comes after …
-
Minghui reports positive topline data from trial of MH004 for atopic dermatitis
Minghui Pharmaceutical has reported positive topline outcomes from the randomised Phase III trial of its pan-Jak inhibitor, MH004 (tofacitinib etocomil) …
-
‘Pill-on-a-thread’ cancer screening trial commences with first patients
A pivotal investigator-led clinical trial for a new ‘pill-on-a-thread’ innovation for oesophageal cancer screening has welcomed its first patients, Cambridge …
-
Tryptamine Therapeutics completes dosing in obesity trial of TRP-8803
Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of its psilocin-based intravenous …
-
Albus demonstrates device’s ability to detect asthma attacks in children
UK-based Albus Health (formerly BreathOx) has shared data revealing that its Albus Home AI-powered monitoring device can detect warning signs …
-
Takeda Canada co-sponsors grant to boost IBD clinical research
Takeda Canada has co-sponsored the Canadian Inflammatory Bowel Disease Research Consortium (CIRC) PIONEER Grant to boost clinical research efforts. The company …
-
New breast cancer combo sees success in New York trial
A new combination therapy designed for some of the most aggressive forms of breast cancer has shown promising results in …
-
Radiopharmaceutical trials face extra complexities due to nuclear red tape
The field of radiopharmaceuticals is growing rapidly, with a real buzz in oncology around emerging therapies. Radiopharmaceuticals are drugs that …
-
Galderma’s prurigo nodularis trial of nemolizumab meets endpoints
Galderma has reported that the randomised Phase III OLYMPIA 1 trial, which evaluated the nemolizumab monotherapy in adult subjects with …
-
Leading lead generation providers and technology solutions for the clinical trials industry
Leading lead generation providers and technology solutions for the clinical trials industry: Introduction The clinical trials sector is a critical component …
-
Telix Pharma doses first patient in Phase III PET carcinoma trial
Australian biotechnology company, Telix Pharmaceuticals, has announced that it has dosed the first patient as part of its Phase III …
